Jeffrey I. Jones

Jeffrey I. Jones

Auto-generated profile, based on publicly available information

Jeffrey I. Jones

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TNTrung T. Nguyen
Trung T. Nguyen
DDDerong Ding
Derong Ding
WWWilliam R. Wolter
William R. Wolter
RPRocio L. Pérez
Rocio L. Pérez
MCMatthew M. Champion
Matthew M. Champion
MCMayland Chang
Mayland Chang

22 May 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JJJeffrey I. Jones
Jeffrey I. Jones
TNTrung Nguyen
Trung Nguyen
ZPZhihong Peng
Zhihong Peng
MCMayland Chang
Mayland Chang
Diabetic foot ulcers (DFUs) are significant complications of diabetes and an unmet medical need. Matrix metalloproteinases (MMPs) play important roles in the pathology of wounds and in the wound healing process. However, because of the challenge in distinguishing active MMPs from the two catalytically inactive forms of MMPs and the clinical failure of broad-spectrum MMP inhibitors in cancer, MMPs have not been a target for treatment of DFUs until recently. This review covers the discovery of active MMP-9 as the biochemical culprit in the recalcitrance of diabetic wounds to healing and targeting this proteinase as a novel approach for the treatment of DFUs. Active MMP-8 and MMP-9 were observed in mouse and human diabetic wounds using a batimastat affinity resin and proteomics. MMP-9 was shown to play a detrimental role in diabetic wound healing, whereas MMP-8 was beneficial. A new class of selective MMP-9 inhibitors shows clinical promise for the treatment of DFUs.

1 April 2016 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
WDW. Sean Davidson
W. Sean Davidson
AHAnna Heink
Anna Heink
HSHannah Sexmith
Hannah Sexmith
JMJohn T. Melchior
John T. Melchior
SGScott M. Gordon
Scott M. Gordon
ASAmy Shah
Amy Shah
High density lipoprotein (HDL) cholesterol efflux function may be a more robust biomarker of coronary artery disease risk than HDL cholesterol (HDL-C). To study HDL function, apoB containing lipoproteins are precipitated from serum. Whether apoB precipitation affects HDL subspecies composition and function has not been thoroughly investigated. We studied the effects of four common apoB precipitation methods (polyethylene glycol (PEG), dextran sulfate/MgCl2, heparin sodium/MnCl2 and LipoSep immunoprecipitant (IP)) on HDL subspecies composition, apolipoproteins and function (cholesterol efflux and reduction of LDL oxidation). PEG dramatically shifted the size distribution of HDL and apolipoproteins (assessed by two independent methods), while leaving substantial amounts of reagent in the sample. PEG also changed the distribution of cholesterol efflux and LDL oxidation across size fractions, but not overall efflux across the HDL range. Dextran sulfate/MgCl2 and heparin sodium/MnCl2 did not change the size distribution of HDL subspecies but altered the quantity of a subset of apolipoproteins. LipoSep IP resulted in a shift in the HDL size distribution, but less so than PEG. Thus, each of the apoB precipitation methods affected HDL composition and/or size distribution. We conclude that careful evaluation is needed when selecting apoB depletion methods for existing and future bioassays of HDL function.

1 January 2017 in Journal of Proteomics
Verified
Journal Article
Closed access
CTChristopher A Toth
Christopher A Toth
ZKZsuzsanna Kuklenyik
Zsuzsanna Kuklenyik
JJJeffrey I Jones
Jeffrey I Jones
BPBryan A Parks
Bryan A Parks
MGMichael S Gardner
Michael S Gardner
JBJohn R Barr
John R Barr

10 April 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZKZsuzsanna Kuklenyik
Zsuzsanna Kuklenyik
JJJeffery I. Jones
Jeffery I. Jones
MGMichael S. Gardner
Michael S. Gardner
DSDavid M. Schieltz
David M. Schieltz
BPBryan A. Parks
Bryan A. Parks
JBJohn Barr
John Barr
Lipoproteins are complex molecular assemblies that are key participants in the intricate cascade of extracellular lipid metabolism with important consequences in the formation of atherosclerotic lesions and the development of cardiovascular disease. Multiplexed mass spectrometry (MS) techniques have substantially improved the ability to characterize the composition of lipoproteins. However, these advanced MS techniques are limited by traditional pre-analytical fractionation techniques that compromise the structural integrity of lipoprotein particles during separation from serum or plasma. In this work, we applied a highly effective and gentle hydrodynamic size based fractionation technique, asymmetric flow field-flow fractionation (AF4), and integrated it into a comprehensive tandem mass spectrometry based workflow that was used for the measurement of apolipoproteins (apos A-I, A-II, A-IV, B, C-I, C-II, C-III and E), free cholesterol (FC), cholesterol esters (CE), triglycerides (TG), and phospholipids (PL) (phosphatidylcholine (PC), sphingomyelin (SM), phosphatidylethanolamine (PE), phosphatidylinositol (PI) and lysophosphatidylcholine (LPC)). Hydrodynamic size in each of 40 size fractions separated by AF4 was measured by dynamic light scattering. Measuring all major lipids and apolipoproteins in each size fraction and in the whole serum, using total of 0.1 ml, allowed the volumetric calculation of lipoprotein particle numbers and expression of composition in molar analyte per particle number ratios. Measurements in 110 serum samples showed substantive differences between size fractions of HDL and LDL. Lipoprotein composition within size fractions was expressed in molar ratios of analytes (A-I/A-II, C-II/C-I, C-II/C-III. E/C-III, FC/PL, SM/PL, PE/PL, and PI/PL), showing differences in sample categories with combinations of normal and high levels of Total-C and/or Total-TG. The agreement with previous studies indirectly validates the AF4-LC-MS/MS approach and demonstrates the potential of this workflow for characterization of lipoprotein composition in clinical studies using small volumes of archived frozen samples.

11 August 2017 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Open access
MGMichael Gardner
Michael Gardner
LMLisa G. McWilliams
Lisa G. McWilliams
JJJeffrey I. Jones
Jeffrey I. Jones
ZKZsuzsanna Kuklenyik
Zsuzsanna Kuklenyik
JPJames L. Pirkle
James L. Pirkle
JBJohn Barr
John Barr
We demonstrate the application of in-source nitrogen collision-induced dissociation (CID) that eliminates the need for ester hydrolysis before simultaneous analysis of esterified cholesterol (EC) a...